Project Grant R43GM146508

Award Date 4/1/22
Completion Date 6/30/23
Dollars Obligated $700K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Torrance, CA 90501, USA
Similar Awards
This Project Grant award of $665,616 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports the development of a novel micro-capsule technology to enable high-throughput analysis of millions of live cell-cell interactions in parallel. The technology aims to address a major unmet need in screening functional antibodies and peptides, evaluating ligand-receptor specificity, and determining cell adhesion affinities....
This National Science Foundation (NSF) Biological Sciences program project grant, awarded to Oregon Health & Science University (OHSU), aims to uncover the underlying biophysical mechanisms of directed cell migration. The $1,049,497 grant, with a period of performance from January 2024 to December 2027, will examine how actin cytoskeletal networks and adhesion receptors interact as interdependent subsystems to facilitate matrix-guided cell migration, which is crucial for tissue formation and...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $955,521 to Yale University to conduct a cross-scale analysis of cell-extracellular matrix (ECM) adhesion in early spinal column development using zebrafish as a model organism. The project aims to quantify the molecular dynamics of single integrin heterodimers, which are the primary cell surface...
This $600,120 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports the development of a groundbreaking microfluidic-based weighing instrument capable of measuring mass changes in live single cells with picogram accuracy and millisecond resolution. The Icahn School of Medicine at Mount Sinai, a prominent academic medical research institution, will lead this 4-year research project. The instrument will utilize small pipettes to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $541,967 to the University of Chicago to investigate the mechanical behaviors of cells and their impact on physiological processes and diseases. The research aims to expand the understanding of adherent cell mechanics and mechanobiology, focusing on the force-sensitive remodeling of cell-cell adhesions and the role of LIM...
This $2,862,000 project grant from the National Institutes of Health's National Institute of General Medical Sciences will support research into the molecular regulation of mechanotransduction over a three-year period ending in August 2025. The grant recipient, the Massachusetts Institute of Technology, will investigate how focal adhesions form and mature to transmit mechanical forces across the plasma membrane through integrin receptors. The researchers will take advantage of a novel...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
This Project Grant awarded by the National Center for Advancing Translational Sciences (NCATS), under the CFDA Program 93.350, provides $306,872 to Millennial Materials & Devices Inc., a minority-owned small business, to develop an integrated 3D printed platform for efficient sample preparation and separation of proteins from limited-volume biological samples for proteomics research. The goal is to fabricate customized 3D printed carbon microbead stationary phase materials and integrated...

HIGH THROUGHPUT SINGLE CELL LINEAR DISPLACEMENT ADHESION ASSAY - ABSTRACT CELL ADHESION IS AN ESSENTIAL PROCESS FOR ANY LIVING CELL. IT IS CRITICAL FOR CELL DIFFERENTIATION, DIVISION, MIGRATION AND SPECIALIZATION. DYSFUNCTION OF CELL ADHESION IS A HALLMARK OF VARIOUS PATHOLOGICAL PHENOTYPES, INCLUDING CHRONIC KIDNEY DISEASES, CANCER, AND MANY OTHERS. IN THE EFFORT TO DISCOVER NEW DISEASE TREATMENTS AND IMPROVE OUR BASIC UNDERSTANDING OF SINGLE CELL PROPERTIES THERE IS A STRONG DEMAND FOR METHODS PERMITTING RAPID AND ACCURATE SINGLE CELL ADHESION MEASUREMENTS. UNFORTUNATELY, CURRENT TECHNOLOGIES ARE LACKING SINCE THEY ONLY MEASURE ADHESION IN ENTIRE CELL POPULATIONS (E.G., MICROFLUIDICS, SPIN DISKS) RATHER THAN INDIVIDUAL CELLS, ARE TOO COMPLEX OR COSTLY (E.G., ATOMIC FORCE MICROSCOPY, OPTICAL TWEEZERS) FOR WIDESPREAD ADOPTION, REQUIRE SOPHISTICATED FUNCTIONALIZED SURFACES (TRACTION FORCE MICROSCOPY), OR PROBE ONLY TARGETED RECEPTORS (CELL ADHESIVE FORCE MICROSCOPY) THAT PRECLUDES MEASURING TOTAL CELL ADHESION POTENTIAL. THEREFORE, THERE IS A GREAT NEED FOR AN AUTOMATED, HIGH-THROUGHPUT AND COST-EFFICIENT PLATFORM CAPABLE OF SIMULTANEOUSLY MEASURING SINGLE CELL ADHESION FOR A LARGE POPULATION OF CELLS. HERE, WE PROPOSE TO DEVELOP A NOVEL METHODOLOGICAL APPROACH UTILIZING SIMPLE DISPOSABLE MICROFLUIDICS CASSETTES (MICS), OSCILLATION DRIVEN CELL SHIFTS, AND A CONVERSION OF EACH INDIVIDUAL CELL TRACK TO ADHESION FORCE VIA MACHINE LEARNING ALGORITHMS. OUR INITIAL STUDIES PROVIDE STRONG SUPPORT FOR THE FEASIBILITY OF THE APPROACH. THIS ONE-YEAR PHASE I PROJECT WILL RESULT IN A FULLY FUNCTIONAL INSTRUMENT THROUGH THE DEVELOPMENT AND INTEGRATION OF ITS CRITICAL COMPONENTS, WHICH INCLUDE A PROGRAMMABLE CELL SHIFT ACTUATOR (BIOSHAKE), DISPOSABLE MICS, CELL ADHESION ANALYSIS ALGORITHMS, AND SOFTWARE (SA1). IN ADDITION, THE ENTIRE WORKFLOW AND PROOF OF PRINCIPLE EXPERIMENTS WILL BE PERFORMED USING MULTIPLE CELL LINES WITH VARIOUS ADHESIVE PROPERTIES (SA2). WE ANTICIPATE THAT THE FULLY DEVELOPED MATURE PRODUCT WILL PROVIDE A HIGH IMPACT TOOL TO PROMOTE MECHANOBIOLOGY STUDIES ON THE KEY ROLE OF CELL ADHESION IN HEALTH AND DISEASE, INCLUDING SUCH PATHOLOGICAL CONDITIONS, SUCH AS CANCER, THUS FACILITATING FURTHER FUNDAMENTAL STUDIES IN CELL BIOLOGY AND TRANSLATIONAL RESEARCH.

Posted 3/24/22, 12:00 AM